IRB Barcelona has put in place structures to ensure that the Institute delivers on the full promise of its potential.
The IRB Barcelona Board of Trustees, or Patronat, is the governing body of the Institute and is responsible for overseeing research activities, approving the operating funds and ensuring that the annual goals are met. The Board is composed of nine members and is chaired by the Minister of Business and Knowledge of the Government of Catalonia.
MEMBERS
Francesc Subirada
General Director for Research
Department of Business and Knowledge
Government of Catalonia
Domènec Espriu Climent
Vicerector of Research
University of Barcelona
Francisco Ciruela Alférez
Rector's delegate for strategic research actions
UB representative at LERU
University of Barcelona
Rafael Pardo
President of Fundación BBVA
Juan Modolell
Centro de Biología Molecular - CSIC
Jerzy Duszynski
Nencki Institute of Experimental Biology
Warsaw, Poland
The scientific work of IRB Barcelona is regularly assessed by an External Advisory Board which comprises 15 leading international researchers in biomedicine. Its main task is to provide guidance in shaping our research and related activities.
Dr. Joan Massagué, chair
Sloan Kettering Institute
New York - USA
Dr. Dario Alessi
University of Dundee
Dundee - UK
Prof. Dr. Annette G. Beck-Sickinger
Institute of Biochemistry
Leipzig - Germany
Dr. Michael Czech
University of Massachusetts
Worcester, MA - USA
Dr. Anne Ephrussi
European Molecular Biology Laboratory (EMBL)
Heidelberg - Germany
Dr. David M. Glover
University of Cambridge
Cambridge - UK
Dr. Jesús Jiménez-Barbero
CICbioGUNE
Derio - Spain
Dr. Johanna Joyce
Memorial Sloan Kettering Cancer Center (MSKCC)
New York, NY - USA
Dr. Carlos López-Otín
Universidad de Oviedo
Oviedo - Spain
Dr. Thomas Muir
Princeton University
Princeton, NJ - USA
Dr. Luis F. Parada
UT Southwestern Medical Center
Dallas, TX - USA
Dr. Dinshaw J. Patel
Memorial Sloan Kettering Cancer Center
New York - USA
Dr. Gertrud Schupbach
Princeton University
Princeton – USA
Dr. Derek Tan
Memorial Sloan Kettering Cancer Center
New York - USA
Dr. Alfonso Valencia
Barcelona Supercomputing Center (BSC)
Barcelona - Spain
Maria C. Freire
Chair
President
NIH Foundation
Pau Bruguera
Chief Technology Officer
Biokit
Begoña Carreño-Gómez
Head Search & Evaluation Primary Care. Global BD&L
Novartis Pharma AG
Laia Crespo
Investment Manager
Ysios Capital
Remi Droller
Managing Partner
KLS Partners
Joël Jean-Mairet
Managing Partner and co-Founder
Ysios Capital
Eva Méndez
Drug Discovery Advisor
Carlos Plata
Chief Scientific Officer
Esteve
Thomas von Rüden
Investment Consultant
Shailendra Vyakarnam
Director
Centre for Entrepreneurial Learning
Cambridge Judge Business School
University of Cambridge
The Internal Scientific Committee is the executive committee in charge of enhancing and coordinating the scientific activity of the institute. The members of the Internal Scientific Committe include the Programme Coordinators and is chaired by the Director. The Chairs of the PhD Committee and the Research Integrity Committee, the Managing Director and the Head of the Research and Academic Administration Department (who also acts as secretary) also participate in the Internal Scientific Committee meetings, which take place every two months.
Joan J. Guinovart
Chair
Modesto Orozco
Interim
The PhD Advisory Committee is the body responsible for shaping PhD training and mentoring activities and identifying and implementing future goals. The committee is comprised of Group Leaders from each Research Programme and the Chair of Graduate Training. Two students from the Student Council, the Academic Officer and the Section Head of the Academic and International Scientific Affairs Office (who also acts as secretary) also participate in the PhD Advisory Committee meetings.
Raúl Méndez
Chair
The aim of the Committee for Research Integrity (CRI) is to promote initiatives related to research integrity, to oversee the implementation of the Code of Conduct, to act as a consulting body, and to conduct any investigations deemed necessary. The CRI is currently in process of defining more specifically the tasks and actions for the near future, including training and prevention. The CRI is formed by the Director, the Managing Director, the Head of an Administration Department, and four representatives from Group Leaders and Core Facility Managers.
Núria López-Bigas
Chair
Bibiana Cervelló
Secretary
The EDC’s main mission is to develop a strategy through which to monitor equality and diversity issues and to provide support and guidance in the implementation of policies and action plans related to the same.
Neus Prats (chair)
Isabel Gordaliza
Jelena Urosevic
Gonzalo Fernández-Miranda
Lidia Pérez
Maria Mácias
Xavier Salvatella
Sònia Saborit
Sylvia Martínez
Claudia Vera (secretary)
